国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
23期
52-55
,共4页
甲状腺功能亢进%心脏病%早期诊断
甲狀腺功能亢進%心髒病%早期診斷
갑상선공능항진%심장병%조기진단
Hyperthyroidism%Heart disease%Early diagnosis
目的 总结和分析甲状腺功能亢进性心脏病的临床诊治特点.方法 回顾性分析72例甲状腺功能亢进性心脏病的临床资料.结果 甲状腺功能亢进性心脏病占同期住院甲状腺功能亢进患者的21.3%,主要表现为心律失常,其占全部甲状腺功能亢进性心脏病的87.5%,其次为心脏增大、心力衰竭和心绞痛分别为41.7%、13.9%和2.8%.甲亢性心脏病的误诊率为16.7%.经抗甲亢和对症治疗后,甲亢性心脏病治愈64例.临床好转6例,死亡2例.结论 年轻和早期甲亢性心脏病的患者,经适当治疗后可完全治愈.年老及病程长者预后不良.早期诊断、避免误诊、合理治疗是甲亢性心脏病治愈的关键.
目的 總結和分析甲狀腺功能亢進性心髒病的臨床診治特點.方法 迴顧性分析72例甲狀腺功能亢進性心髒病的臨床資料.結果 甲狀腺功能亢進性心髒病佔同期住院甲狀腺功能亢進患者的21.3%,主要錶現為心律失常,其佔全部甲狀腺功能亢進性心髒病的87.5%,其次為心髒增大、心力衰竭和心絞痛分彆為41.7%、13.9%和2.8%.甲亢性心髒病的誤診率為16.7%.經抗甲亢和對癥治療後,甲亢性心髒病治愈64例.臨床好轉6例,死亡2例.結論 年輕和早期甲亢性心髒病的患者,經適噹治療後可完全治愈.年老及病程長者預後不良.早期診斷、避免誤診、閤理治療是甲亢性心髒病治愈的關鍵.
목적 총결화분석갑상선공능항진성심장병적림상진치특점.방법 회고성분석72례갑상선공능항진성심장병적림상자료.결과 갑상선공능항진성심장병점동기주원갑상선공능항진환자적21.3%,주요표현위심률실상,기점전부갑상선공능항진성심장병적87.5%,기차위심장증대、심력쇠갈화심교통분별위41.7%、13.9%화2.8%.갑항성심장병적오진솔위16.7%.경항갑항화대증치료후,갑항성심장병치유64례.림상호전6례,사망2례.결론 년경화조기갑항성심장병적환자,경괄당치료후가완전치유.년로급병정장자예후불량.조기진단、피면오진、합리치료시갑항성심장병치유적관건.
Objective To sum up the clinical feature of diagnosis and treatment on patients with hyper-thyroid heart disease .Methods The clirrical data of 72 cases with hyperthyroid heart disease were analyzed retrospectively. Results The patients with hyperthyroid heart disease were 213% of all patients with hyperthyrnid who were received into hospital in same time.87.5% patients with hyperthyroid heart disease presented arrhythmia,and heart enlargement, heart failure,angina were 41.7%,13.9% and 2.8% respectively.The misdiagnosis rate were 16.7%.After the treatment of symptomatic treatment and anti-hyperthyreosis treabnent,64 cases with hyperthyroid heart disease were cured,6 cases were unproved and 2 patients died.Conclusions When the patients were young and the course were in the earlier stage,patients who were with hyperthyroid heart disease can be completely curedjut the prognosis were poor if the patients were old and the the course of disease was in the late stage. Without misdiagnosis,earlier and reasonable treatments are critical of hyperthyroid heart disease.
